in type 2 diabetic patients , fasting hyperglycaemia ( 10.6 +/- 1.1 mmol/l ) and hepatic glucose production ( 15 +/- 2 mumol x kg-1 x min-1 ) fell upon asa treatment ( 8.6 +/- 0.7 mmol/l ; 13 +/- 1 mumol x kg-1 x min-1 ) .
C0020456
hyperglycaemia
C0017725
glucose